Thermofisher Remel Bactipstaph Latex Kits 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Thermo Fisher Scientific Australia & New Zealand 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2017-RN-01410-1
  • 사례 위험등급
    Class II
  • 사례 시작날짜
    2017-11-13
  • 사례 국가
  • 사례 출처
    DHTGA
  • 사례 출처 URL
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    An internal technical investigation by remel has confirmed that the positive control supplied within these kits may be non-reactive. the latex test reagent provided in the kits performs exactly as expected and according to specifications.No other batches or pack sizes of this product are affected.
  • 조치
    Thermofisher is advising users to inspect stock and quarantine any remaining units of the affected batch from use. The requirement for a review of previously generated results is at the discretion of the Laboratory Director.

Device

  • 모델명 / 제조번호(시리얼번호)
    Thermofisher Remel Bactipstaph Latex Kits Items Numbers: R21143Lot Numbers: 104809ARTG number 235680 (Thermo Fisher Scientific Australia & New Zealand - Microbial-isolate identification and testing IVDs)
  • Manufacturer

Manufacturer